Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Jun 19;13(6):e0199164.
doi: 10.1371/journal.pone.0199164. eCollection 2018.

Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component

Sergio Caravita  1   2 , Andrea Faini  2 , Sandy Carolino D'Araujo  1 , Céline Dewachter  1 , Laura Chomette  1 , Antoine Bondue  1 , Robert Naeije  1 , Gianfranco Parati  2   3 , Jean-Luc Vachiéry  1
Affiliations
Comparative Study

Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component

Sergio Caravita et al. PLoS One. .

Abstract

Background: In pulmonary hypertension (PH), both wedge pressure elevation (PAWP) and a precapillary component may affect right ventricular (RV) afterload. These changes may contribute to RV failure and prognosis. We aimed at describing the different haemodynamic phenotypes of patients with PH due to left heart disease (LHD) and at characterizing the impact of pulmonary haemodynamics on RV function and outcome PH-LHD.

Methods: Patients with PH-LHD were compared with treatment-naïve idiopathic/heritable pulmonary arterial hypertension (PAH, n = 35). PH-LHD patients were subdivided in Isolated post-capillary PH (IpcPH: diastolic pressure gradient, DPG<7 mmHg and pulmonary vascular resistance, PVR≤3 WU, n = 37), Combined post- and pre-capillary PH (CpcPH: DPG≥7 mmHg and PVR>3 WU, n = 27), and "intermediate" PH-LHD (either DPG <7 mmHg or PVR ≤3 WU, n = 29).

Results: Despite similar PAWP and cardiac index, haemodynamic severity and prevalence of RV dysfunction increased from IpcPH, to "intermediate" and CpcPH. PVR and DPG (but not compliance, Ca) were linearly correlated with RV dysfunction. CpcPH had worse prognosis (p<0.05) than IpcPH and PAH, but similar to "intermediate" patients. Only NTproBNP and Ca independently predicted survival in PH-LHD.

Conclusions: In PH-LHD, haemodynamic characterization according to DPG and PVR provides important information on disease severity, predisposition to RV failure and prognosis. Patients presenting the CpcPH phenotype appear to have haemodynamic profile closer to PAH but with worse prognosis. In PH-LHD, Ca and NTproBNP were independent predictors of survival.

PubMed Disclaimer

Conflict of interest statement

JLV is the holder of the Actelion Research Chair on Pulmonary Hypertension in his department. SC is the recipient of a ERS PAH Short-Term Research Training Fellowship (STRTF 2014-5264) supported by an unrestricted grant by GSK, and of the international grant “Cesare Bartorelli” for the year 2014 funded by the Italian Society of Hypertension. This does not alter our adherence to PLOS ONE policies on sharing data and materials. None of the other authors has a financial relationship with a commercial entity that has an interest in the subject of the present manuscript or other conflicts of interest to disclose.

Figures

Fig 1
Fig 1. Effects of varying the diastolic pressure gradient and pulmonary artery wedge pressure on the compliance-resistance relationship in patients with pulmonary hypertension.
Panel a): pulmonary arterial compliance as a function of pulmonary vascular resistance, both logarithmically transformed. Panel b): resistance-compliance product as a function of pulmonary artery wedge pressure. Ca = pulmonary arterial compliance; DPG = diastolic pressure gradient; PAH = pulmonary arterial hypertension; PH-LHD = pulmonary hypertension due to left heart disease; PVR = pulmonary vascular resistance; RC-time = pulmonary vascular resistance-compliance product.
Fig 2
Fig 2
Prevalence of echocardiographic signs of right ventricular dysfunction in the four groups of patients as a function of pulmonary haemodynamics: pulmonary vascular resistance (panel a), diastolic pressure gradient (panel b), and pulmonary arterial compliance (panel c). Ca = pulmonary arterial compliance; CpcPH = combined post- and pre-capillary pulmonary hypertension; DPG = diastolic pressure gradient; Interm = intermediate; IpcPH = isolated post-capillary pulmonary hypertension; PAH = pulmonary arterial hypertension; PVR = pulmonary vascular resistance; RV = right ventricle.
Fig 3
Fig 3. Kaplan-Meier curves of survival for patients with pulmonary arterial hypertension and patients with pulmonary hypertension due to left heart disease.
In the panel a) patients with pulmonary hypertension due to left heart disease are all pooled together, while in the panel b) they are subdivided in three groups according to the diastolic pressure gradient and pulmonary vascular resistance. CpcPH = combined post- and pre-capillary pulmonary hypertension; Interm = intermediate PH-LHD; IpcPH = isolated post-capillary pulmonary hypertension; PAH = pulmonary arterial hypertension; PH-LHD = pulmonary hypertension due to left heart disease.
See this image and copyright information in PMC

References

    1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46:903–75 doi: 10.1183/13993003.01032-2015 - DOI - PubMed
    1. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 2013;62:D100–8 doi: 10.1016/j.jacc.2013.10.033 - DOI - PubMed
    1. Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013;41:217–23 doi: 10.1183/09031936.00074312 - DOI - PubMed
    1. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest 2013;143:758–66. doi: 10.1378/chest.12-1653 - DOI - PubMed
    1. Gerges M, Gerges C, Lang IM. How to define pulmonary hypertension due to left heart disease. Eur Respir J 2016; 48(2):553–5 doi: 10.1183/13993003.00432-2016 - DOI - PubMed

Publication types

MeSH terms